Jastrzebskal, M <br/><br/>
Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms.  [electronic resource] 

 -  Nutrition, metabolism, and cardiovascular diseases : NMCD  Oct 2004 
 - 259-69 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0939-4753 
<br/><br/><label>Standard No.: </label>10.1016/s0939-4753(04)80053-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Analysis of Variance<br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Antihypertensive Agents--therapeutic use<br/>Fibrinogen--drug effects<br/>Genetic Predisposition to Disease<br/>Hemostasis--genetics<br/>Humans<br/>Hypertension--blood<br/>Male<br/>Peptidyl-Dipeptidase A--drug effects<br/>Perindopril--therapeutic use<br/>Phenotype<br/>Plasminogen Activator Inhibitor 1--genetics<br/>Polymorphism, Genetic<br/>Treatment Outcome